echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Safety of N-DESMETHYL IMATINIB

    The Safety of N-DESMETHYL IMATINIB

    • Last Update: 2023-04-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Introduction


    N-Desmethyl Imatinib is a medication used to treat various types of cancer, including chronic myeloid leukemia, gastrointestinal stromal tumors, and systemic mastocytosis.
    It is also known by its brand name, Glivec.
    As with any medication, it is important to ensure the safety of N-Desmethyl Imatinib for both patients and those working in the chemical industry.


    Chemical Properties of N-Desmethyl Imatinib


    N-Desmethyl Imatinib is a white to off-white powder with a molecular formula of C28H38N6O2.
    It has a molecular weight of 508.
    5 g/mol and is practically insoluble in water.
    It is highly soluble in ethanol and acetonitrile, however, making it a suitable solvent for many chemical reactions.


    Safety Considerations for N-Desmethyl Imatinib


    When handling N-Desmethyl Imatinib, it is important to take proper safety precautions to prevent exposure to the medication.
    This can include wearing protective gloves, safety glasses, and a lab coat.
    It is also important to handle the medication in a well-ventilated area to prevent inhalation of any fumes that may be produced.


    In addition to handling the medication safely, it is important to store N-Desmethyl Imatinib in a safe and secure location to prevent unauthorized access.
    This can include locking the medication in a secure cabinet or storing it in a restricted area.


    Proper disposal of N-Desmethyl Imatinib is also essential to prevent harm to the environment and to human health.
    It should be disposed of in accordance with local regulations and guidelines for the disposal of medical waste.


    Toxicity of N-Desmethyl Imatinib


    N-Desmethyl Imatinib is considered to be a toxic medication and can cause serious side effects if not used properly.
    It is classified as a Category 2 medication according to the World Health Organization's (WHO) hazard classification system.
    This means that it is potentially harmful to human health if swallowed, inhaled, or if it comes into contact with the skin.


    In the event of accidental exposure to N-Desmethyl Imatinib, it is important to seek medical attention immediately.
    Symptoms of exposure may include nausea, vomiting, diarrhea, and abdominal pain.
    In severe cases, it may cause difficulty breathing, convulsions, or even death.


    Conclusion


    N-Desmethyl Imatinib is an important medication used to treat various types of cancer.
    However, it is also a toxic chemical that requires proper handling and storage to ensure the safety of both patients and those working in the chemical industry.
    It is important to take proper safety precautions when handling N-Desmethyl Imatinib and to dispose of it in accordance with local regulations and guidelines for the disposal of medical waste.
    By taking these precautions, we can minimize the risk of harm to human health and the environment.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.